Last reviewed · How we verify
lidocaine inhalation; intravenous dexamethasone
lidocaine inhalation; intravenous dexamethasone is a Small molecule drug developed by Indonesia University. It is currently in Phase 1 development.
At a glance
| Generic name | lidocaine inhalation; intravenous dexamethasone |
|---|---|
| Sponsor | Indonesia University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Opioid Free Anesthesia vs. Opioid Anesthesia Techniques. (PHASE2, PHASE3)
- Comparison Between Lidocaine Inhalation and Intravenous Dexamethasone in Reducing Pain After Laryngeal Mask Insertion (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- lidocaine inhalation; intravenous dexamethasone CI brief — competitive landscape report
- lidocaine inhalation; intravenous dexamethasone updates RSS · CI watch RSS
- Indonesia University portfolio CI
Frequently asked questions about lidocaine inhalation; intravenous dexamethasone
What is lidocaine inhalation; intravenous dexamethasone?
lidocaine inhalation; intravenous dexamethasone is a Small molecule drug developed by Indonesia University.
Who makes lidocaine inhalation; intravenous dexamethasone?
lidocaine inhalation; intravenous dexamethasone is developed by Indonesia University (see full Indonesia University pipeline at /company/indonesia-university).
What development phase is lidocaine inhalation; intravenous dexamethasone in?
lidocaine inhalation; intravenous dexamethasone is in Phase 1.
Related
- Manufacturer: Indonesia University — full pipeline